Fund manager Hendrik Leber reveals his preferred stocks for the year 2025.
Swipe to Reveal Dr. Hendrik Leber's Undervalued Stock Picks for 2025's First Half
Dr. Leber gives his stock market predictions for 2025 and reveals some promising stocks to watch.
Dr. Hendrik Leber, renowned fund manager of ACATIS Investment Company, shared his insights on the stock market for the year 2025. Let's dive into the stocks he thinks are worth investigating in the first half.
Reliable Investments: Dr. Leber's Picks
Dr. Leber proposes three primary investment sectors: IT, biotechnology, and infrastructure. His favorite in the IT sector is none other than the innovative company, Palantir, known for its technology edge and long-term potential. In the biotechnology sphere, Dr. Leber sees potential investments despite inherent uncertainties present in this field.
Two outstanding companies he suggests keeping an eye on are Regeneron and Genmab, both showing long-term potential. A surprising candidate, according to Dr. Leber, is BioNTech. With the ambitious goal of conducting 19 clinical trials for the new drug BNT32007, BioNTech showcases determination in the fight against cancer. This progress has already caused a 10% surge in its stock price. Listen to him explain: "BioNTech, the surprising candidate I foresee, will conduct 19 clinical trials for a new drug called BNT32007."
When it comes to infrastructure, Dr. Leber is excited about investing in a proposed hydrogen network, set to receive 20 billion euros in funding and potentially be a game-changer in energy supply in the long run.
However, he asserts that the biotech sector currently offers the most intriguing opportunities from a valuation perspective.
Inexpensive Gems: Undervalued Stocks to Buy
So why does Dr. Leber predict disappointment in the stock market's second half? What's his perspective on AI stocks like Nvidia, cryptocurrencies like Bitcoin, and value stocks? How should investors prepare for the stock market in 2025? Find out in his exclusive interview on the Börse ONLINE YouTube channel.
Before you go, don't miss: Bitcoin: Are Bad Days Ahead? What Happens if the Cryptocurrency Crashes at 100,000 Dollars?
Learning Points
- Dr. Leber's insight: The stock market will be positive in the first half of 2025, but there may be setbacks afterward.
- Strong contenders: Palantir (IT), Regeneron, Genmab, and BioNTech (biotechnology), and a new hydrogen network (infrastructure) are promising investments.
- Biotech's appeal: Dr. Leber believes the biotech sector currently offers the best investment opportunities.
- Get the whole story: To learn more about AI stocks, cryptocurrencies, and value stocks, watch Dr. Leber's entire interview on the Börse ONLINE YouTube channel.
- Additional Reading: Bitcoin: Are Bad Days Ahead? What Happens if the Cryptocurrency Crashes at 100,000 Dollars?
In the first half of 2025, Dr. Leber advises investigating promising stocks such as Palantir from the IT sector, Regeneron and Genmab in the biotechnology field, and a potential hydrogen network in infrastructure. Among the biotech stocks, Dr. Leber finds the current opportunities particularly favorable due to their undervalued status, with BioNTech being a noteworthy example.
